GARUDA THERAPEUTICS

garuda-therapeutics-logo

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

GARUDA THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2021-01-01

Address:
Natick, Massachusetts, United States

Country:
United States

Website Url:
http://www.garudatx.com

Total Employee:
51+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
72 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Mobile Non Scaleable Content


Similar Organizations

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

gentibio-logo

GentiBio

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

kyverna-therapeutics-logo

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

octant-bio-logo

Octant Bio

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

taysha-gene-therapies-logo

Taysha Gene Therapies

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

wugen-logo

Wugen

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies


Current Advisors List

carl-l-gordon_image

Carl L. Gordon Board Member @ Garuda Therapeutics
Board_member
2021-09-01

shaan-gandhi_image

Shaan Gandhi Board Member @ Garuda Therapeutics
Board_member
2021-09-01

rahul-singhvi_image

Rahul Singhvi Board Member @ Garuda Therapeutics
Board_member
2021-09-01

eric-aguiar_image

Eric Aguiar Board Member @ Garuda Therapeutics
Board_member
2021-09-01

Current Employees Featured

not_available_image

Dhvanit Shah
Dhvanit Shah Founder, President, and Chief Executive Officer @ Garuda Therapeutics
Founder, President, and Chief Executive Officer

james-desiderio_image

James Desiderio
James Desiderio Chief Regulatory Officer @ Garuda Therapeutics
Chief Regulatory Officer
2022-03-01

Founder


not_available_image

David Scadden

not_available_image

Dhvanit Shah

not_available_image

Sean Morrison

Investors List

mass-general-brigham-ventures_image

Mass General Brigham Ventures

Mass General Brigham Ventures investment in Series A - Garuda Therapeutics

ridgeback-capital_image

Ridgeback Capital

Ridgeback Capital investment in Series A - Garuda Therapeutics

northpond-ventures_image

Northpond Ventures

Northpond Ventures investment in Series A - Garuda Therapeutics

sectoral-asset-management_image

Sectoral Asset Management

Sectoral Asset Management investment in Series A - Garuda Therapeutics

monashee-investment_image

Monashee Investment Management

Monashee Investment Management investment in Series A - Garuda Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Garuda Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series A - Garuda Therapeutics

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series A - Garuda Therapeutics

resilience-e701_image

Resilience

Resilience investment in Series A - Garuda Therapeutics

Official Site Inspections

http://www.garudatx.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.81 K

  • Host name: 74-208-236-97.elastic-ssl.ui-r.com
  • IP address: 74.208.236.97
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Garuda Therapeutics"

Garuda Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases. It seeks to create a world that eliminates the dependency on donor or patient cells for โ€ฆSee details»

Garuda Therapeutics - Overview, News & Similar companies

Jan 9, 2024 View Garuda Therapeutics (www.garudatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Garuda Therapeutics Company Overview, Contact Details

Be The Match BioTherapies partnered with Garudatx on May 24th '23. Be The Match BioTherapies®, an organization offering solutions for companies developing and โ€ฆSee details»

Garuda Therapeutics - LinkedIn

Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self ...See details»

Garuda Therapeutics Named โ€œOverall Cell Biology โ€ฆ

LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology ...See details»

Garuda - Company Profile - Tracxn

Nov 27, 2024 Email ID: *****@garudatx.com; Key Metrics. Total Funding. $182M in 3 rounds. Latest Funding Round. Series B, Oct 17, 2024, $47.7M. Investors. Orbimed & 10 more. โ€ฆSee details»

Garuda Therapeutics - Company Profile & Staff Directory

Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the โ€ฆSee details»

Garuda Therapeutics - VentureRadar

Similar Companies: Cell BioEngines, Inc USA Privately Held Cell BioEngines, Inc., is a venture-backed immunotherapy company focused on developing 'off-the-shelf' allogenic cell therapies โ€ฆSee details»

Garuda Therapeutics - workinbiotech.com

Garuda Therapeutics is developing โ€œoff-the-shelfโ€, durable blood stem cell therapies to treat a range of diseases. Hematopoietic stem cells (HSCs) can be used to generate many different โ€ฆSee details»

Garuda Therapeutics - BIO International Convention | BIO

Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Garuda โ€ฆSee details»

Scale Up Scientist / Senior Scientist โ€“ Process Development

Scale Up Scientist / Senior Scientist โ€“ Process Development. Garuda Therapeutics, a biotechnology company focused on developing off-the-shelf human hematopoietic stem cell โ€ฆSee details»

Cell-Based Assay Associate / Senior Associate โ€“ Analytical โ€ฆ

Cell-Based Assay Associate / Senior Associate โ€“ Analytical Development . Garuda Therapeutics, a biotechnology company focused on developing off-the-shelf human hematopoietic stem cell โ€ฆSee details»

Be The Match BioTherapies® To Provide Robust Cell Therapy

MINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Be The Match BioTherapies ®, an organization offering solutions for companies developing and commercializing cell and gene โ€ฆSee details»

Garuda Therapeutics Launches with $72 Million Series A Financing

CAMBRIDGE, Mass.โ€“(BUSINESS WIRE)โ€“Garuda Therapeutics, a company creating off-the-shelf, durable blood stem cell therapies, launched today with an oversubscribed $72 million โ€ฆSee details»

Careers โ€“ Garuda - garudatx.com

Garuda Therapeutics, a biotechnology company focused on developing off-the-shelf human hematopoietic stem cell-based cellular therapies, is seeking a highly motivated Associate โ€ฆSee details»

Garuda Therapeutics Launches with $72 Million Series A Financing

Sep 23, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Garuda Therapeutics, a company creating off-the-shelf, durable blood stem cell therapies, launched today with an โ€ฆSee details»

Associate Director / Director โ€“ Regulatory CMC โ€“ Garuda

Please contact [email protected] to share your resume and learn more. Facebook; Twitter; LinkedIn; E-Mail; Comments are closed. Contact Info 22 Strathmore Road Natick, MA 01760 โ€ฆSee details»

Pluripotent Stem Cell Scientist / Senior Scientist โ€“ Process ...

Natick, MA 01760 USA E-Mail: [email protected]. Apply Now " *" indicates required fields. Name * First Last. Email * Phone * Upload Resume. Accepted file types: pdf, doc, docx, Max. โ€ฆSee details»

Privacy Policy โ€“ Garuda - garudatx.com

Privacy Policy Last Updated: September 1, 2021. This Privacy Policy describes how Garuda Therapeutics, Inc. (โ€œGarudaโ€, โ€œweโ€, โ€œusโ€, โ€œourโ€) handles ...See details»

linkstock.net © 2022. All rights reserved